Skip to main content
1-877-936-8422
VICC
Search
Main navigation
Home
Patient Care
Cancer Care Overview
Find a Doctor
Request an Appointment
Find a Clinical Trial
MyHealth at Vanderbilt
Support & Education
Cancer Information
Clinical Trials
Clinical Trials Overview
Frequently Asked Questions
Trial Search for Physicians
Trial Search For Patients
Flowcharts
Research
Research Overview
Research Programs
Shared Resources
Clinical Trials
Member Directory
Membership Information
Funding Opportunities
Seminars & Lectures
Giving
Giving & Impact
Make a Gift
Donor-Supported Research
Volunteer
Community
Community Overview
Health Disparities
Advocacy
VICC Ambassadors
Community Events
Education
Education, Training, and Career Development
Annual Scientific Retreat
Seminar Series
Seminars & Lectures
About
About Vanderbilt-Ingram
Leadership
Fast Facts
History
Careers
News Center
For Media
Event Calendar
Momentum magazine
More
Intranet (for faculty and staff)
About the site
Help
Contact the web team
Prices
Search
at Vanderbilt-Ingram Cancer Center
Site Search
All
Pages
Members
Clinical Trials
News
Events
Clinics & Services
1267 results found
Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas
Relevance:
1
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
Relevance:
1
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Relevance:
1
A Study to Evaluate INCA033989 Administered in Participants With Myeloproliferative Neoplasms
Relevance:
1
Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease
Relevance:
1
A Phase 1 Study of AB521 in Renal Cell Carcinoma and Other Solid Tumors
Relevance:
1
Nivolumab and Ipilimumab for the Treatment of Patients with Locally Advanced, Metastatic, or Unresectable Liver Cancer
Relevance:
1
Avelumab or Hydroxychloroquine with or without Palbociclib for the Treatment of Stage II-III Breast Cancer, PALAVY Study
Relevance:
1
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Relevance:
1
Vorinostat in Preventing Graft Versus Host Disease in Children, Adolescents, and Young Adults Undergoing Blood and Bone Marrow Transplant
Relevance:
1
Pagination
Previous page
‹ previous
…
Page
55
Page
56
Page
57
Page
58
Current page
59
Page
60
Page
61
Page
62
Page
63
…
Next page
next ›